Advertisement

Internal and Emergency Medicine

, Volume 5, Supplement 1, pp 53–56 | Cite as

Gut microbiota and obesity

  • Emidio Scarpellini
  • Mariachiara Campanale
  • Diana Leone
  • Flaminia Purchiaroni
  • Giovanna Vitale
  • Ernesto Cristiano Lauritano
  • Antonio Gasbarrini
Selected Paper: Gut Microbiota and Related Diseases

Abstract

Intestinal epithelium, mucosal immune system, and bacterial flora represent a morpho-functional system on dynamic balance responsible for the intestinal metabolic and trophic functions, and the regulation of mucosal and systemic host’s immunity. Obesity is a pathological condition affecting a growing number of people especially in the Western countries resulting from the failure of the organism’s energetic balance based on the perfect equality of income, waste, and storage. Recent evidences explain the mechanisms for the microbial regulation of the host’s metabolism both in health and disease. In particular, animal studies have explained how quali-/quantitative changes in microflora composition are able to affect the absorption of the nutrients and the energy distribution. Antibiotics, prebiotics, probiotics, and symbiotics are the instruments utilized in the current clinical practice to modulate the intestinal bacterial flora in man both in health and pathologic conditions with promising preliminary results on prevention and therapy of obesity and related metabolic diseases.

Keywords

Obesity Microflora Metabolism Probiotics Rifaximin 

Notes

Acknowledgments

This work was supported by an unrestricted grant provided by Fondazione Ricerca in Medicina.

Conflict of interest

None.

References

  1. 1.
    Simon GL, Gorbach SL (1984) Intestinal flora in health and disease. Gastroenterology 86:174–193PubMedGoogle Scholar
  2. 2.
    Berg R (1996) The indigenous gastrointestinal microflora. Trends Microbiol 4:430–435CrossRefPubMedGoogle Scholar
  3. 3.
    Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI (2001) Molecular analysis of commensal host–microbial relationships in the intestine. Science 291:881–884CrossRefPubMedGoogle Scholar
  4. 4.
    Tannock GW (2001) Molecular assessment of intestinal microflora. Am J Clin Nutr 73:S410–S414Google Scholar
  5. 5.
    Hooper LV, Gordon JI (2001) Commensal host–bacterial relationships in the gut. Science 292:1115–1118CrossRefPubMedGoogle Scholar
  6. 6.
    Macpherson AJ, Harris NL (2004) Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 4:478–485CrossRefPubMedGoogle Scholar
  7. 7.
    Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R (2004) Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118:229–241CrossRefPubMedGoogle Scholar
  8. 8.
    Gasbarrini A, Lauritano EC, Garcovich M, Sparano L, Gasbarrini G (2008) New insights into the pathophysiology of IBS: intestinal microflora, gas production and gut motility. Eur Rev Med Pharmacol Sci 1:111–117Google Scholar
  9. 9.
    Gasbarrini A, Lauritano EC, Gabrielli M et al (2007) Small intestinal bacterial overgrowth: diagnosis and treatment. Dig Dis 25:237–240CrossRefPubMedGoogle Scholar
  10. 10.
    Siebler J, Galle PR, Weber MM (2008) The gut-liver-axis: endotoxemia, inflammation, insulin resistance and NASH. J Hepatol 48:1032–1034CrossRefPubMedGoogle Scholar
  11. 11.
    Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444:860–867CrossRefPubMedGoogle Scholar
  12. 12.
    Falk PG, Hooper LV, Midtvedt T, Gordon JI (1998) Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiol Mol Biol Rev 62:1157–1170PubMedGoogle Scholar
  13. 13.
    Ley RE, Turnbaugh PJ, Klein S, Gordon JI (2006) Microbial ecology: human gut microbes associated with obesity. Nature 444:1022–1023CrossRefPubMedGoogle Scholar
  14. 14.
    Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI (2004) The gut microbiota as an environment factor that regulates fat storage. Proc Natl Acad Sci USA 101:15718–15723CrossRefPubMedGoogle Scholar
  15. 15.
    Turnbaugh PJ, Gordon JI (2009) The core gut microbiome, energy balance and obesity. J Physiol 587:4153–4158CrossRefPubMedGoogle Scholar
  16. 16.
    Turnbaugh PJ, Bäckhed F, Fulton L, Gordon JI (2008) Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 17:213–223CrossRefGoogle Scholar
  17. 17.
    Bäckhed F, Manchester JK, Semenkovich CF, Gordon JI (2007) Mechanisms underlying the resistance to diet induced obesity in germ-free mice. Proc Natl Acad Sci USA 104:979–984CrossRefPubMedGoogle Scholar
  18. 18.
    Tilg H, Moschen AR, Kaser A (2009) Obesity and the microbiota. Gastroenterology 136:1476–1483CrossRefPubMedGoogle Scholar
  19. 19.
    DiBaise JK, Zhang H, Crowell MD, Krajmalnik-Brown R, Decker GA, Rittmann BE (2008) Gut microbiota and its possible relationship with obesity. Mayo Clin Proc 83:460–469CrossRefPubMedGoogle Scholar
  20. 20.
    Cani PD, Delzenne NM, Amar J, Burcelin R (2008) Role of gut microflora in the development of obesity and insulin resistance following high-fat diet feeding. Pathol Biol 56:305–309CrossRefPubMedGoogle Scholar
  21. 21.
    Cani PD, Neyrinck AM, Fava F et al (2007) Selective increases of bifidobacteria in gut microflora improves high-fat diet induced diabetes in mice through a mechanism associated with endotoxiemia. Diabetologia 50:2374–2383CrossRefPubMedGoogle Scholar
  22. 22.
    Ojetti V, Lauritano EC, Barbaro F et al (2009) Rifaximin pharmacology and clinical implications. Expert Opin Drug Metab Toxicol 5:675–682CrossRefPubMedGoogle Scholar
  23. 23.
    Musso G, Gambino R, Cassader M (2010) Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders. Curr Opin Lipidol 21:76–83CrossRefPubMedGoogle Scholar
  24. 24.
    Cani PD, Lecourt E, Dewulf EM et al (2009) Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr 90:1236–1243CrossRefPubMedGoogle Scholar
  25. 25.
    Nilsson AC, Ostman EM, Holst JJ, Bjorck IM (2008) Including indigestible carbohydrates in the evening meal of healthy subjects improves glucose tolerance, lowers inflammatory markers, and increases satiety after a subsequent standardized breakfast. J Nutr 138:732–739PubMedGoogle Scholar
  26. 26.
    Parnell JA, Reimer RA (2009) Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am J Clin Nutr 89:1751–1759CrossRefPubMedGoogle Scholar
  27. 27.
    Solga SF, Buckley G, Clark JM (2008) The effect of a probiotic on hepatic steatosis. J Clin Gastroenterol 42:1117–1118CrossRefPubMedGoogle Scholar

Copyright information

© SIMI 2010

Authors and Affiliations

  • Emidio Scarpellini
    • 1
  • Mariachiara Campanale
    • 1
  • Diana Leone
    • 1
  • Flaminia Purchiaroni
    • 1
  • Giovanna Vitale
    • 1
  • Ernesto Cristiano Lauritano
    • 1
  • Antonio Gasbarrini
    • 1
  1. 1.Internal Medicine Department, Gemelli HospitalCatholic University of Sacred HeartRomeItaly

Personalised recommendations